DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

Virology

Volumn 246, Issue 1, 1998, Pages 134-144

  Vanderzanden, Lorna ^a   Bray, Mike ^a   Fuller, Deborah ^b   Roberts, Tim ^b   Custer, David ^a   Spik, Kristin ^a   Jahrling, Peter ^a   Huggins, John ^a   Schmaljohn, Alan ^a   Schmaljohn, Connie ^a  

^a Dept of Immunol and Molec Biology Bldg 1425 U States Army Med R   (United States)

^b PowderJect Vaccines Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BIOLISTIC TRANSFORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; EBOLA VIRUS; FEMALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SURVIVAL; VACCINATION; VIRUS ENVELOPE; VIRUS GENE; VIRUS INFECTION; VIRUS NUCLEOCAPSID;

ANIMALIA; EBOLA VIRUS; RNA VIRUSES;

EID: 0032551189     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9176     Document Type: Article

References (44)

1. Arikawa, J., Schmaljohn, A., Schmaljohn, C., and Dalrymple, J. (1989). Characterization of Hantaan virus envelope glycoprotein antigenic determinants by monoclonal antibodies. J. Gen. Virol. 70, 615-624.
2. Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., and Muggins, J. (1996). "A Mouse Model for Evaluation of Ebola Prophylaxis and Therapy." International Colloquium on Ebola Virus Research. 4-7 September, Antwerp, Belgium. [Abstract]
3. Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., and Huggins, J. (1998). A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. [in press]
4. Buchmeier, M. J., DeFries, R. U., McCormick, J. B., and Kiley, M. P. (1983). Comparative analysis of the structural polypeptides of Ebola viruses from Sudan and Zaire. J. Infect. Dis. 147, 276-281.
5. Centers for Disease Control (1995a). Update: Outbreak of Ebola viral hemorrhagic fever - Zaire, 1995. Morb. Mortal. Wkly. Rep. 44, 399.
6. Centers for Disease Control (1995b). Outbreak of Ebola viral hemorrhagic fever - Zaire, 1995. Morb. Mortal. Wkly. Rep. 44, 381-382.
7. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D., Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2, 1122-1128.
8. Eisenbraun, M. D., Fuller, D. H., and Haynes, J. R. (1993). Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12, 791-797.
9. Elliott, L. H., Kiley, M. P., and McCormick, J. B. (1985). Descriptive analysis of Ebola virus proteins. Virology 147, 169-176.
10. Elliott, L. H., Sanchez, A., Holloway, B. P., Kiley, M. P., and McCormick, J. B. (1993). Ebola protein analyses for the determination of genetic organization. Arch. Virol. 133, 423-436.
11. Feldmann, H., and Klenk, H. D. (1996). Marburg and Ebola viruses. Adv. Virus Res. 47, 1-52.
12. Feldmann, H., Nichol, S. T., Klenk, H. D., Peters, C. J., and Sanchez, A. (1994). Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199, 469-473.
13. Feldmann, H., Will, C., Schikore, M., Slenczka, W., and Klenk, H. D. (1991). Glycosylation and oligomerization of the spike protein of Marburg virus. Virology 182, 353-356.
14. Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122-8126.
15. Fuller, D. H., and Haynes, J. R. (1994). A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10, 1433-1441.
16. Fuller, D. H., Corb, M. M., Barnett, S., Steimer, K., and Haynes, J. R. (1997). Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 15, 924-926.
17. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1993). DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
18. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1995). DNA vaccines: A novel approach to immunization. Int. J. Immunopharmacol. 17, 79-83.
19. Geisbert, T. W., and Jahrling, P. B. (1990). Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic. J Clin. Pathol. 43, 813-816.
20. Gilligan, K. J., Geisbert, J. B., Jahrling, P. B., and Anderson, K. A. (1997). Assessment of protective immunity conferred by recombinant vaccinia viruses to guinea pigs challenged with Ebola virus. In "Vaccines 97," pp. 87-92. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Haynes, J. R., Fuller, D. H., Eisenbraun, M. D., Ford, M. J., and Pertmer, T. M. (1994). Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses. AIDS Res. Hum. Retroviruses 10(Suppl 2), 543-554.
22. Hevey, M., Negley, D., Geisbert, J., Jahrling, P., and Schmaljohn, A. (1997). Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology 239, 206-216.
23. Iacono-Connors, L., Smith, J., Ksiazek, T., Kelley, C., and Schmaljohn, C. (1996). Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody. Virus Res. 43, 125-136.
24. Jaax, N., Jahrling, P., Geisbert, T., Geisbert, J., Steele, K., McKee, K., Nagley, D., Johnson, E., Jaax, G., and Peters, C. (1995). Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory [see comments]. Lancet 346, 1669-1671.
25. Jahrling, P. B., Geisbert, J., Swearengen, J. R., Jaax, G. P., Lewis, T., Huggins, J. W., Schmidt, J. J., LeDuc, J. W., and Peters, C. J. (1996). Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. Suppl. 11, 135-140.
26. Jahrling, P. B., Geisbert, T. W., Dalgard, D. W., Johnson, E. D., Ksiazek, T. G., Hall, W. C., and Peters, C. J. (1990). Preliminary report: Isolation of Ebola virus from monkeys imported to USA. Lancet 335, 502-505.
27. Johnson, K. M., Lange, J. V., Webb, P. A., and Murphy, F. A. (1977). Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1, 569-571.
28. Kiley, M. P., Cox, N. J., Elliott, L. H., Sanchez, A., DeFries, R., Buchmeier, M. J., Richman, D. D., and McCormick, J. B. (1988). Physicochemical properties of Marburg virus: Evidence for three distinct virus strains and their relationship to Ebola virus. J. Gen. Virol. 69, 1957-1967.
29. Kiley, M. P., Regnery, R. L., and Johnson, K. M. (1980). Ebola virus: Identification of virion structural proteins. J. Gen. Virol. 49, 333-341.
30. Le Guenno, B., Formentry, P., Wyers, M., Gounon, P., Walker, F., and Boesch, C. (1995). Isolation and partial characterisation of a new strain of Ebola virus [see comments]. Lancet 345, 1271-1274.
31. Mikhailov, V. V., Borisevich, I. V., Chernikova, N. K., Potryvaeva, N. V., and Krasnianskii, V. P. (1994). [The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever]. Vopr. Virusol. 39, 82-84.
32. Pertmer, T. M., Eisenbraun, M. D., McCabe, D., Prayaga, S. K., Fuller, D. H., and Haynes, J. R. (1995). Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427-1430.
33. Peters, C. J., Sanchez, A., Feldmann, H., Rollin, P. E., Nichol, S., and Ksiazek, T. G. (1994). Filoviruses as emerging pathogens. Semin. Virol. 5, 147-154.
34. Sanchez, A., Kiley, M. P., Holloway, B. P., and Auperin, D. D. (1993). Sequence analysis of the Ebola virus genome: Organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29, 215-240.
35. Sanchez, A., Ksiazek, T. G., Rollin, P. E., Peters, C. J., Nichol, S. T., Khan, A. S., and Mahy, B. W. (1995). Reemergence of Ebola virus in Africa. Emerg. Infect. Dis. 1, 96-97. [editorial]
36. Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., and Nichol, S. T. (1996). The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA 93(8), 3602-3607.
37. Schmaljohn, C., VanderZanden, L., Bray, M., Custer, D., Meyer, B., Li, D., Rossi, C., Fuller, D., Fuller, J., Haynes, J., and Huggins, J. (1997). Naked DNA vaccines expressing the prM and E genes of Russian Spring Summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71, 9563-9569.
38. Stingl, G. (1993). The skin: Initiation and target site of immune responses. Recent Results Cancer Res. 128, 45-57.
39. Ulmer, J. B., Deck, R. R., Yawman, A., Friedman, A., Dewitt, C., Martinez, D., Montgomery, D. L., Donnelly, J. J., and Liu, M. A. (1996a). DNA vaccines for bacteria and viruses. Adv. Exp. Med. Biol. 397, 49-53.
40. Ulmer, J. B., Donnelly, J. J., Deck, R. R., DeWitt, C. M., and Liu, M. A. (1995). Immunization against viral proteins with naked DNA. Ann. N.Y. Acad. Sci. 772, 117-125.
41. Ulmer, J. B., Sadoff, J. C., and Liu, M. A. (1996b). DNA vaccines. Curr. Opin. Immunol. 8, 531-536.
42. Volchkov, V. E., Becker, S., Volchkova, V. A., Ternovoj, V. A., Kotov, A. N., Netesov, S. V., and Klenk, H. D. (1995). GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214, 421-430.
43. Whalen, R. G. (1996). DNA vaccines for emerging infectious diseases: What if? Emerg. Infect. Dis. 2, 168-175.
44. Xu, L., Sanchez, A., Yang, Z.-Y., Zaki, S. R., Nabel, E. G., Nichol, S. T., and Nabel, G. J. (1998). Immunization for Ebola virus infection. Nature Med. 4, 37-42.